Scarica l'app Stockscreener
5.01
1.01%
0.05
Dopo l'orario di chiusura:
5.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Maravai LifeSciences Holdings, Inc. (MRVI) tops Q1 earnings and revenue estimates - MSN
Insider Sell: Kurt Oreshack Sells 50,000 Shares of Maravai LifeS - GuruFocus
Maravai LifeSciences general counsel Oreshack sells $253,999 shares - Investing.com
Maravai Lifesciences Holdings Insider Sold Shares Worth $254,000, According to a Recent SEC Filing - Moomoo
MRVI (MRVI) CEO Brust reports 351,001-share tax withholding, holds 2.1M shares - Stock Titan
Maravai (NASDAQ: MRVI) General Counsel sells 50,000 shares under 10b5-1 plan - Stock Titan
Maravai Lifesciences director gifts 92,586 shares | MRVI Insider Trading - Stock Titan
Kurt Oreshack notifies sale of 25,000 MRVI Class A shares (NASDAQ: MRVI) - Stock Titan
Maravai (MRVI) brokered sale notice: 25,000 Class A shares via Fidelity - Stock Titan
Maravai LifeSciences refinances debt with $180M credit facilities; lowers outstanding borrowings - MSN
Maravai LifeSciences Projects Strong Annual Revenue and Trims Q1 Net Loss - HarianBasis.co
This is why Maravai Lifesciences Holdings Inc. (MRVI) is a Top penny Stock in the Top Investors Portfolio - Yahoo Finance
MRVI Technical Analysis & Stock Price Forecast - Intellectia AI
MRVI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Investors’ Stock Portfolio: Top 10 Penny Stocks To Buy - Insider Monkey
Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI - ACCESS Newswire
Maravai LifeSciences refinances debt, cuts principal by $92.9M - Investing.com UK
Maravai LifeSciences (MRVI) Secures New $150M Credit Facility - GuruFocus
Maravai LifeSciences refinances debt, cuts principal by $92.9M By Investing.com - Investing.com Australia
Maravai LifeSciences Refinances Debt, Extends Credit Facilities - TipRanks
Maravai LifeSciences Refinances Credit Agreement, Extends Maturity to 2032 - Moomoo
Maravai LifeSciences (NASDAQ: MRVI) cuts debt and extends loan maturity to 2032 - Stock Titan
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032 - Business Wire
Maravai Stock Dips Monday With Eyes on Major Event This Week - Bez Kabli
Maravai LifeSciences Holdings, Inc. 8-K Filing Details for May 26, 2026: Company Information, Stock, and Regulatory Compliance - Minichart
Maravai Lifesciences Shareholders Back Board, Pay, Auditor - TipRanks
Maravai LifeSciences (MRVI) shareholders approve directors, auditor and pay at 2026 meeting - Stock Titan
All you need to know about Maravai LifeSciences (MRVI) rating upgrade to buy - MSN
Maravai (MRVI) director granted 46,293 restricted stock units - Stock Titan
Maravai LifeSciences (MRVI) Surges Over 6% as Biotech Sector Shows Signs of LifeRisk Parity Rebalance - thelegaladvocate.com
Director-linked entity at Maravai (NASDAQ: MRVI) awarded 46,293 RSUs - Stock Titan
Maravai (MRVI) director Susannah Gray receives 46,293-share stock unit award - Stock Titan
Maravai (MRVI) director Mihas receives 46,293 RSUs held for GTCR-affiliated entity - Stock Titan
Maravai LifeSciences (MRVI) director receives 46,293-share RSU award - Stock Titan
[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity - Stock Titan
RSU grant to GTCR-affiliated entity via Maravai (MRVI) director - Stock Titan
Maravai (MRVI) director awarded 46,293 RSUs in equity grant - Stock Titan
Maravai LifeSciences (MRVI) Holds Tight Near Support Amid Minimal Price MovementIntraday Profile - thelegaladvocate.com
Earnings Preview: MRVI to Report Financial Results Post-market on February 25 - Moomoo
Maravai (MRVI) officer granted 5,006 ESPP shares at $1.79 - Stock Titan
Maravai Lifesciences (NASDAQ: MRVI) counsel gets 776 ESPP shares - Stock Titan
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference - Business Wire
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI) - Seeking Alpha
Maravai LifeSciences Holdings, Inc.Class A common stock (NQ: MRVI - The Chronicle-Journal
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Viola - The National Law Review
Maravai LifeSciences Holdings (MRVI) price target increased by 23.91% to 5.81 - MSN
12 West Capital Amends 13G, Holds 7.26M Shares in Maravai (MRVI) - Stock Titan
Maravai LifeSciences Q1 Turnaround Spurs Rethink Of CleanCap Driven Outlook - Sahm
How The Maravai LifeSciences (MRVI) Narrative Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Maravai LifeSciences stock (US56600D1072): Q1 turnaround and CleanCap momentum draw fresh investor a - AD HOC NEWS
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):